{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:14:59Z","timestamp":1742184899884,"version":"3.38.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.canep.2024.102536","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T05:07:27Z","timestamp":1706418447000},"page":"102536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0640-1505","authenticated-orcid":false,"given":"Kuan-Yu","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian-Seng","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Nien","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che-Yuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Chuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Ting","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Tzu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong-Chin","family":"Jou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzong-Shin","family":"Tzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuh-Shyan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2024.102536_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canep.2024.102536_bib2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1342::AID-CNCR17>3.0.CO;2-B","article-title":"Unusual clinical presentation of upper urothelial carcinoma in Taiwan","volume":"85","author":"Chou","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2024.102536_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ijc.28013","article-title":"Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes","volume":"133","author":"Chen","year":"2013","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.canep.2024.102536_bib4","article-title":"New malignancies among cancer survivors: SEER cancer registries, 1973-2000: US Department of Health and Human Services, National Institutes of Health","author":"Curtis","year":"2006","journal-title":"NIH pubi"},{"key":"10.1016\/j.canep.2024.102536_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0090-4295(02)01529-7","article-title":"Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan","volume":"59","author":"Yang","year":"2002","journal-title":"Urology"},{"issue":"11_Part_2","key":"10.1016\/j.canep.2024.102536_bib6","first-page":"5895","article-title":"Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers","volume":"45","author":"Chen","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.canep.2024.102536_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/aje\/153.5.411","article-title":"Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan","volume":"153","author":"Chiou","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canep.2024.102536_bib8","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)","volume":"342","author":"Nortier","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canep.2024.102536_bib9","series-title":"Health Hazards of Environmental Arsenic Poisoning: From Epidemic to Pandemic","article-title":"Arsenics and urothelial carcinoma","author":"Chen","year":"2011"},{"key":"10.1016\/j.canep.2024.102536_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jnci\/djp467","article-title":"Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk","volume":"102","author":"Lai","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canep.2024.102536_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1158\/1055-9965.EPI-20-1090","article-title":"Additive effects of arsenic and aristolochic acid in chemical carcinogenesis of upper urinary tract urothelium","volume":"30","author":"Chen","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canep.2024.102536_bib12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41568-022-00494-x","article-title":"Aristolochic acid-associated cancers: A public health risk in need of global action","volume":"22","author":"Das","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canep.2024.102536_bib13","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canep.2024.102536_bib14","doi-asserted-by":"crossref","unstructured":"Report WG: International rules for multiple primary cancers (ICD-0 third edition). Eur J Cancer Prev. 2005;14(4):307\u2013308. \u3008https:\/\/doi.org\/10.1097\/00008469\u2013200508000-00002\u3009.","DOI":"10.1097\/00008469-200508000-00002"},{"key":"10.1016\/j.canep.2024.102536_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/bju.13351","article-title":"Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients","volume":"118","author":"Muller","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.canep.2024.102536_bib16","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/cncr.28769","article-title":"Risk of second primary tumors in men diagnosed with prostate cancer: A population-based cohort study","volume":"120","author":"Davis","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2024.102536_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1756287210374462","article-title":"Secondary malignancies following radiotherapy for prostate cancer","volume":"2","author":"Sountoulides","year":"2010","journal-title":"Ther. Adv. Urol."},{"key":"10.1016\/j.canep.2024.102536_bib18","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/1097-0142(19860901)58:5<1158::AID-CNCR2820580530>3.0.CO;2-V","article-title":"Risk of second malignancy after cancers of the renal parenchyma, renal pelvis, and ureter","volume":"58","author":"Kantor","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2024.102536_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00052939","article-title":"Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91","volume":"7","author":"McCredie","year":"1996","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canep.2024.102536_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1377\/hlthaff.22.3.61","article-title":"Taiwan's new national health insurance program: Genesis and experience so far","volume":"22","author":"Cheng","year":"2003","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.canep.2024.102536_bib21","first-page":"1","article-title":"Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey","volume":"4.1","author":"Liu","year":"2006","journal-title":"J. Health Manag"},{"key":"10.1016\/j.canep.2024.102536_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ijc.32101","article-title":"Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States","volume":"145","author":"Adjei Boakye","year":"2019","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.canep.2024.102536_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eururo.2020.05.039","article-title":"Molecular characterization of upper tract urothelial carcinoma in the era of next-generation sequencing: a systematic review of the current literature","volume":"78","author":"Hassler","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canep.2024.102536_bib24","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","article-title":"Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum","volume":"54","author":"Roupr\u00eat","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canep.2024.102536_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jso.22074","article-title":"Six primary cancers in one Lynch syndrome patient with chronic arsenic exposure","volume":"105","author":"Chen","year":"2012","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.canep.2024.102536_bib26","doi-asserted-by":"crossref","first-page":"197ra102","DOI":"10.1126\/scitranslmed.3006200","article-title":"Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing","volume":"5","author":"Hoang","year":"2013","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.canep.2024.102536_bib27","doi-asserted-by":"crossref","first-page":"197ra101","DOI":"10.1126\/scitranslmed.3006086","article-title":"Genome-wide mutational signatures of aristolochic acid and its application as a screening tool","volume":"5","author":"Poon","year":"2013","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.canep.2024.102536_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00302751","article-title":"The carcinogenic action of aristolochic acid in rats","volume":"51","author":"Mengs","year":"1982","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.canep.2024.102536_bib29","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1158\/1055-9965.EPI-16-0219","article-title":"Aristolochic acid in the etiology of renal cell carcinoma","volume":"25","author":"Hoang","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canep.2024.102536_bib30","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/ijc.31544","article-title":"Health data analysis in Taiwan (hDATa) Research Group: Herbal medicine containing aristolochic acid and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection","volume":"143","author":"Chen","year":"2018","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.canep.2024.102536_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan6446","article-title":"Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia","volume":"9","author":"Ng","year":"2017","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.canep.2024.102536_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154023","article-title":"Aristolochic acid and the risk of cancers in patients with type 2 diabetes: Nationwide population-based cohort study","volume":"99","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canep.2024.102536_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1940-6207.CAPR-15-0339","article-title":"Hepatic premalignant alterations triggered by human nephrotoxin aristolochic acid I in canines","volume":"9","author":"Jin","year":"2016","journal-title":"Cancer Prev. Res (Philos. )"},{"key":"10.1016\/j.canep.2024.102536_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.etp.2016.03.003","article-title":"Oral exposure to aristolochic acid I induces gastric histological lesions with non-specific renal injury in rat","volume":"68","author":"Pu","year":"2016","journal-title":"Exp. Toxicol. Pathol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782124000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782124000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T01:58:05Z","timestamp":1742176685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782124000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":34,"alternative-id":["S1877782124000158"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2024.102536","relation":{},"ISSN":["1877-7821"],"issn-type":[{"type":"print","value":"1877-7821"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2024.102536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102536"}}